Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release

Cardiovascular Research

Volumn 72, Issue 2, 2006, Pages 292-302

  Hove Madsen, Leif ^a   Prat Vidal, Cristina ^a   Llach, Anna ^a   Ciruela, Francisco ^b   Casadó, Vicent ^b   Lluis, Carme ^b   Bayes Genis, Antoni ^a   Cinca, Juan ^a   Franco, Rafael ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenosine; Arrhythmia (mechanisms); Calcium channel; e c coupling; SR (function)

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR; CALCIUM; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; RECEPTOR SUBTYPE; RYANODINE RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL; ADENOSINE; CAFFEINE; DRUG DERIVATIVE; ISOQUINOLINE DERIVATIVE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHENETHYLAMINE DERIVATIVE; RYANODINE; SODIUM CALCIUM EXCHANGE PROTEIN; SULFONAMIDE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CALCIUM CURRENT; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM RECEPTOR; HEART RIGHT ATRIUM; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MEMBRANE CURRENT; PATCH CLAMP; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; WESTERN BLOTTING; AGED; CHEMISTRY; DRUG ANTAGONISM; HEART ATRIUM; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STIMULATION;

ADENOSINE; AGED; CAFFEINE; CALCIUM; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HEART ATRIA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOQUINOLINES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHENETHYLAMINES; RECEPTORS, ADENOSINE A2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RYANODINE; SARCOPLASMIC RETICULUM; SODIUM-CALCIUM EXCHANGER; STIMULATION, CHEMICAL; SULFONAMIDES;

EID: 33749586497     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.07.020     Document Type: Article

References (43)

1. Pogwizd S.M., Qi M., Yuan W., Samarel A.M., and Bers D.M. Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85 (1999) 1009-1019
2. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
3. Reiken S., Gaburjakova M., Guatimosim S., Gomez A.M., D'Armiento J., Burkhoff D., et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem 278 (2003) 444-453
4. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113 (2003) 829-840
5. Jiang D., Xiao B., Yang D., Wang R., Choi P., Zhang L., et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A 101 (2004) 13062-13067
6. Hove-Madsen L., Llach A., Bayes-Genis A., Roura S., Rodriguez Font E., Aris A., et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 110 (2004) 1358-1363
7. Schlotthauer K., and Bers D.M. Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ Res 87 (2000) 774-780
8. Burashnikov A., and Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 107 (2003) 2355-2360
9. Jiang D., Xiao B., Zhang L., and Chen S.R. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 91 (2002) 218-225
10. Lehnart S.E., Wehrens X.H., Laitinen P.J., Reiken S.R., Deng S.X., Cheng Z., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214
11. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91 (2002) e21-e26
12. Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F., Gasparini M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
13. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103 (2001) 485-490
14. Vest J.A., Wehrens X.H., Reiken S.R., Lehnart S.E., Dobrev D., Chandra P., et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111 (2005) 2025-2032
15. Reiken S., Wehrens X.H., Vest J.A., Barbone A., Klotz S., Mancini D., et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
16. Dobson Jr. J.G., and Fenton R.A. Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res 34 (1997) 337-347
17. Monahan T.S., Sawmiller D.R., Fenton R.A., and Dobson Jr. J.G. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol 279 (2000) H1472-H1481
18. Xu H., Stein B., and Liang B. Characterization of a stimulatory adenosine A2a receptor in adult rat ventricular myocyte. Am J Physiol 270 (1996) H1655-H1661
19. Boknik P., Neumann J., Schmitz W., Scholz H., and Wenzlaff H. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle. J Cardiovasc Pharmacol 30 (1997) 750-758
20. Kilpatrick E.L., Narayan P., Mentzer Jr. R.M., and Lasley R.D. Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol 282 (2002) H1035-H1040
21. Hein T.W., Wang W., Zoghi B., Muthuchamy M., and Kuo L. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol 33 (2001) 271-282
22. Murphree L.J., Marshall M.A., Rieger J.M., MacDonald T.L., and Linden J. Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4). Mol Pharmacol 61 (2002) 455-462
23. Woodiwiss A.J., Honeyman T.W., Fenton R.A., and Dobson Jr. J.G. Adenosine A2a-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and -dependent mechanisms. Am J Physiol 276 (1999) H1434-H1441
24. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 364-374
25. Burgueno J., Blake D.J., Benson M.A., Tinsley C.L., Esapa C.T., Canela E.I., et al. The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J Biol Chem 278 (2003) 37545-37552
26. Sham J.S., Cleemann L., and Morad M. Functional coupling of Ca2+ channels and ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A 92 (1995) 121-125
27. Satoh H., Blatter L.A., and Bers D.M. Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes. Am J Physiol 272 (1997) H657-H668
28. Cannell M.B., Cheng H., and Lederer W.J. The control of calcium release in heart muscle. Science 268 (1995) 1045-1049
29. Santana L.F., Kranias E.G., and Lederer W.J. Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol 503 Pt 1 (1997) 21-29
30. Lukyanenko V., Viatchenko-Karpinski S., Smirnov A., Wiesner T.F., and Gyorke S. Dynamic regulation of sarcoplasmic reticulum Ca(2+) content and release by luminal Ca(2+)-sensitive leak in rat ventricular myocytes. Biophys J 81 (2001) 785-798
31. Cheng H., Lederer W.J., and Cannell M.B. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262 (1993) 740-744
32. Moschella M.C., and Marks A.R. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J Cell Biol 120 (1993) 1137-1146
33. Mackenzie L., Bootman M.D., Laine M., Berridge M.J., Thuring J., Holmes A., et al. The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541 (2002) 395-409
34. Lipp P., Laine M., Tovey S.C., Burrell K.M., Berridge M.J., Li W., et al. Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr Biol 10 (2000) 939-942
35. Zima A.V., and Blatter L.A. Inositol-1,4,5-trisphosphate-dependent Ca(2+) signalling in cat atrial excitation-contraction coupling and arrhythmias. J Physiol 555 (2004) 607-615
36. Abebe W., and Mustafa S.J. Effects of adenosine analogs on inositol 1,4,5-trisphosphate production in porcine coronary artery. Vascul Pharmacol 39 (2002) 89-95
37. Giovannucci D.R., Groblewski G.E., Sneyd J., and Yule D.I. Targeted phosphorylation of inositol 1,4,5-trisphosphate receptors selectively inhibits localized Ca2+ release and shapes oscillatory Ca2+ signals. J Biol Chem 275 (2000) 33704-33711
38. Wojcikiewicz R.J., and Luo S.G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J Biol Chem 273 (1998) 5670-5677
39. Stange M., Xu L., Balshaw D., Yamaguchi N., and Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem 278 (2003) 51693-51702
40. Xiao B., Jiang M.T., Zhao M., Yang D., Sutherland C., Lai F.A., et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ Res 96 (2005) 847-855
41. Fraser I.D., Tavalin S.J., Lester L.B., Langeberg L.K., Westphal A.M., Dean R.A., et al. A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events. EMBO J 17 (1998) 2261-2272
42. Jurevicius J., and Fischmeister R. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci U S A 93 (1996) 295-299
43. Zaccolo M., and Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295 (2002) 1711-1715